Coastline Trust’s AbbVie ABBV Stock Holding History

Coastline Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3M	Sell	48,854 -750	-2%	-$161K	1.09%	22
2026 Q1	$10.8M	Buy	49,604 +250	+0.5%	+$55.5K	1.07%	24
2025 Q4	$11.3M	Buy	49,354 +10,492	+27%	+$2.39M	1.06%	24
2025 Q3	$9M	Sell	38,862 -50	-0.1%	-$10.2K	0.97%	27
2025 Q2	$7.22M	Sell	38,912 -25	-0.1%	-$4.65K	0.83%	30
2025 Q1	$8.16M	Sell	38,937 -1,669	-4%	-$324K	1.01%	26
2024 Q4	$7.22M	Sell	40,606 -2,238	-5%	-$411K	0.84%	28
2024 Q3	$8.46M	Sell	42,844 -6,036	-12%	-$1.13M	0.99%	23
2024 Q2	$8.38M	Sell	48,880 -992	-2%	-$164K	0.98%	23
2024 Q1	$9.08M	Buy	49,872 +1,381	+3%	+$238K	1.1%	21
2023 Q4	$7.51M	Sell	48,491 -2,307	-5%	-$336K	1%	21
2023 Q3	$7.57M	Sell	50,798 -2,390	-4%	-$351K	1.12%	19
2023 Q2	$7.17M	Sell	53,188 -1,192	-2%	-$175K	1%	18
2023 Q1	$8.67M	Buy	54,380 +2,230	+4%	+$341K	1.28%	15
2022 Q4	$8.43M	Buy	52,150 +3,769	+8%	+$578K	1.26%	13
2022 Q3	$6.49M	Buy	48,381 +10,720	+28%	+$1.54M	1.04%	17
2022 Q2	$5.77M	Buy	37,661 +20	+0.1%	+$3.06K	0.85%	19
2022 Q1	$6.1M	Sell	37,641 -470	-1%	-$68.3K	0.74%	29
2021 Q4	$5.16M	Buy	38,111 +60	+0.2%	+$7.09K	0.59%	50
2021 Q3	$4.1M	Buy	38,051 +775	+2%	+$88.6K	0.51%	61
2021 Q2	$4.2M	Buy	37,276 +2,375	+7%	+$267K	0.52%	59
2021 Q1	$3.78M	Buy	34,901 +5,375	+18%	+$575K	0.49%	66
2020 Q4	$3.16M	Buy	29,526 +1,495	+5%	+$144K	0.42%	74
2020 Q3	$2.46M	Buy	28,031 +1,055	+4%	+$99.3K	0.37%	90
2020 Q2	$2.65M	Sell	26,976 -680	-2%	-$59.9K	0.42%	78
2020 Q1	$2.11M	Buy	27,656 +2,830	+11%	+$241K	0.38%	93
2019 Q4	$2.2M	Buy	24,826 +3,180	+15%	+$264K	0.3%	125
2019 Q3	$1.64M	Sell	21,646 -1,660	-7%	-$114K	0.24%	152
2019 Q2	$1.7M	Buy	23,306 +105	+0.5%	+$8.25K	0.25%	150
2019 Q1	$1.87M	Buy	23,201 +1,950	+9%	+$160K	0.28%	131
2018 Q4	$1.96M	Buy	21,251 +201	+1%	+$17.7K	0.34%	107
2018 Q3	$1.99M	Buy	21,050 +1,380	+7%	+$131K	0.29%	124
2018 Q2	$1.82M	Buy	19,670 +1,290	+7%	+$126K	0.27%	126
2018 Q1	$1.74M	Sell	18,380 -915	-5%	-$101K	0.27%	131
2017 Q4	$1.87M	Sell	19,295 -305	-2%	-$28.7K	0.28%	128
2017 Q3	$1.74M	Buy	19,600 +1,744	+10%	+$133K	0.3%	124
2017 Q2	$1.29M	Buy	17,856 +2,880	+19%	+$194K	0.23%	137
2017 Q1	$975K	Buy	14,976 +1,250	+9%	+$78.6K	0.18%	162
2016 Q4	$860K	Sell	13,726 -450	-3%	-$27.5K	0.17%	171
2016 Q3	$894K	Buy	14,176 +105	+0.7%	+$6.8K	0.17%	167
2016 Q2	$871K	Buy	14,071 +585	+4%	+$35.6K	0.18%	165
2016 Q1	$770K	Buy	13,486 +485	+4%	+$27K	0.16%	170
2015 Q4	$770K	Sell	13,001 -1,865	-13%	-$107K	0.17%	165
2015 Q3	$809K	Buy	14,866 +925	+7%	+$60.2K	0.18%	154
2015 Q2	$937K	Buy	13,941 +4,986	+56%	+$326K	0.2%	144
2015 Q1	$525K	Buy	8,955 +369	+4%	+$22.3K	0.11%	202
2014 Q4	$562K	Buy	8,586 +1,326	+18%	+$83.6K	0.12%	191
2014 Q3	$419K	Sell	7,260 -200	-3%	-$11.1K	0.11%	176
2014 Q2	$421K	Sell	7,460 -100	-1%	-$5.25K	0.11%	169
2014 Q1	$389K	Hold	7,560	–	–	0.1%	176
2013 Q4	$399K	Hold	7,560	–	–	0.11%	170
2013 Q3	$338K	Buy	7,560 +1,530	+25%	+$67.8K	0.1%	171
2013 Q2	$249K	Buy	+6,030	New	+$264K	0.08%	181

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Coastline Trust's ABBV Position: Q2 2026 in Review

Coastline Trust reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $161K and leaving 48,854 shares worth $12.3M. The position accounts for 1.09% of the portfolio, ranked #22.

Coastline Trust first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Coastline Trust held 48,854 shares of AbbVie worth $12.3M as of Q2 2026.
Coastline Trust sold 750 AbbVie shares in Q2 2026, an estimated $161K.
AbbVie made up 1.09% of Coastline Trust's portfolio in Q2 2026, its #22 holding.
Coastline Trust first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Coastline Trust's 13F filing for Q2 2026, filed 14 Aug 2026.